Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s Licence
January 19, 2024 07:30 ET
|
Optimi Health Corp.
Optimi Health granted amendment to its Health Canada Controlled Drugs and Substances Licence.
Vantage Hemp Co. Submits Drug Master File for CBD Isolate to the U.S. Food & Drug Administration
April 04, 2023 07:00 ET
|
Vantage Hemp
Greeley, Colorado, April 04, 2023 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”) announces that it has submitted a Drug Master File (DMF) for its cannabidiol (CBD) Isolate to the...
Global $250+ Bn Pharmaceutical API Manufacturing (Chemical & Biological) Markets, 2016-2021, 2021-2026F, 2031F
April 13, 2022 04:58 ET
|
Research and Markets
Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical API Manufacturing Global Market Report 2022: By Therapy, By API, By Drug" report has been added to ResearchAndMarkets.com's offering. ...
Vantage Hemp Co. is in the Final Stages of its DMF Submissions
January 24, 2022 07:45 ET
|
Vantage Hemp
Greeley, Colorado, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”), an industry-leading manufacturer of pharmaceutical-grade CBD products, today announced that the...